← Back to Search

Other

Plasma Transfusion for Aging (RESET-YOUTH Trial)

Phase 1 & 2
Waitlist Available
Led By Chandra s duggirala
Research Sponsored by Chandra Duggirala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,1,2,3,4,5,6, and 9 months.
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the effects of regular treatments using plasma from young healthy male donors on patients older than 40 years. The goal is to see if the young plasma can rejuvenate the body and improve functions like cognition, muscle strength, and organ health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,1,2,3,4,5,6, and 9 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,1,2,3,4,5,6, and 9 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Biological age as assessed by DNA methylation levels, to calculate the Epigenetic age.
Secondary study objectives
DHEAS
Estrogen
High Sensitivity C-Reactive Protein
+8 more
Other study objectives
Exploratory biomarkers

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Plasma TransfusionExperimental Treatment1 Intervention
Plasma Transfusions with 2 units of plasma per dose, for a total of 6 doses

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Chandra DuggiralaLead Sponsor
Chandra s duggiralaPrincipal InvestigatorFountain Labs, Inc.
~283 spots leftby Nov 2025